Ranbaxy Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Dec' 14	Sep' 14	Jun' 14	Mar' 14	Dec' 13

Sales

1,009.85

1,318.91

2,178.63

1,252.02

1,366.56

Operating profit

-351.50

-155.67

926.39

-37.66

-66.05

Interest

149.31

136.82

141.91

110.85

118.39

Gross profit

-483.05

-272.47

810.24

488.00

-163.84

EPS (Rs)

-33.46

-8.69

17.83

21.21

-9.36

Other income

17.75

20.02

25.76

636.50

20.60

Stock adjustment

46.07

101.17

102.74

3.29

-82.70

Raw material

314.13

335.94

280.73

394.87

432.75

Power and fuel

-

-

-

-

-

Employee expenses

271.89

279.67

254.74

226.27

271.91

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

729.27

757.81

614.03

665.25

810.65

Provisions made

-

-

-

-

-

Depreciation

54.81

60.15

65.65

49.98

45.85

Taxation

855.35

-

9.24

30.57

-

Net profit / loss

-1,420.49

-368.26

755.12

897.86

-395.96

Extra ordinary item

-27.27

-35.63

19.77

490.41

-186.28

Prior year adjustments

-

-

-

-

-

Equity capital

212.24

211.95

211.78

211.66

211.55

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

1562.90

1493.14

1448.53

1487.74

1480.02

Agg.of non promotoholding (%)

36.77

35.22

34.18

35.11

34.93

OPM (%)

-34.81

-11.80

42.52

-3.01

-4.83

GPM (%)

-47.01

-20.35

36.76

25.84

-11.81

NPM (%)

-138.23

-27.50

34.26

47.54

-28.54